Regenxbio Inc (RGNX)
16.87
+0.04
(+0.24%)
USD |
NASDAQ |
May 06, 13:30
Regenxbio Gross Profit (TTM): 53.03M for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 53.03M |
September 30, 2023 | 60.62M |
June 30, 2023 | 57.51M |
March 31, 2023 | 66.70M |
December 31, 2022 | 58.18M |
September 30, 2022 | 415.21M |
June 30, 2022 | 418.46M |
March 31, 2022 | 410.98M |
December 31, 2021 | 418.51M |
September 30, 2021 | 54.10M |
June 30, 2021 | 118.98M |
March 31, 2021 | 118.65M |
December 31, 2020 | 118.85M |
September 30, 2020 | 115.64M |
June 30, 2020 | 46.30M |
March 31, 2020 | 40.37M |
December 31, 2019 | 26.99M |
September 30, 2019 | 56.95M |
Date | Value |
---|---|
June 30, 2019 | 49.53M |
March 31, 2019 | 79.74M |
December 31, 2018 | 208.86M |
September 30, 2018 | 173.35M |
June 30, 2018 | 169.22M |
March 31, 2018 | 138.30M |
December 31, 2017 | 8.684M |
September 30, 2017 | 7.628M |
June 30, 2017 | 7.065M |
March 31, 2017 | 3.697M |
December 31, 2016 | 3.63M |
September 30, 2016 | 5.83M |
June 30, 2016 | 6.623M |
March 31, 2016 | 5.799M |
December 31, 2015 | 6.093M |
September 30, 2015 | 3.524M |
June 30, 2015 | 3.112M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
26.99M
Minimum
Dec 2019
418.51M
Maximum
Dec 2021
142.40M
Average
60.62M
Median
Sep 2023
Gross Profit (TTM) Benchmarks
Sarepta Therapeutics Inc | 1.237B |
Amgen Inc | 19.60B |
Gilead Sciences Inc | 20.80B |
AbbVie Inc | 33.88B |
Bristol-Myers Squibb Co | 34.48B |